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The site on nectin1 receptor required for herpes simplex virus (HSV) entry into the cell was previously mapped to the 64–94
region, encompassing the predicted CCC region of the immunoglobulin V domain. Within it lies a minimal HSV entry site
(residues 77–94). Here we transferred the 65–76 region (C strand and CC loop) and portions, or single amino acids, thereof
to nectin2, a homolog nonfunctional for wt HSV-1 entry. Replacement of the seven- or of three-amino-acid-long stretches from
nectin1 to nectin2 (amino acids 69–75, 69–71, or 72–75) transferred wt HSV-1 and BHV-1 entry activity and enhanced HSV-2,
PrV, and HSV-HSV(U21) entry to levels observed with nectin1. Thus, the CC ridge is sufficient to mediate wt HSV entry at a
reduced level and responsible for the wide virus range of the receptor. Altogether the HSV entry site appears to be composedIntroduction. Herpes simplex virus (HSV) infection is a
multistep process that involves the interaction of viral
envelope glycoproteins and cellular counterparts (for re-
views, see 3, 26). After the initial attachment to cell
surface heparan sulfate by glycoproteins B and C (gB
and gC), entry occurs via the binding of gD to one of its
receptors, followed by fusion between the viral envelope
and the plasma membrane, a process that further in-
volves gD, gB, and gH/gL. The gD receptors belong to
three unrelated molecular families: the nectin family be-
longing to the Ig superfamily (9, 13, 15, 16, 28), tumor
necrosis factor receptor (TNFR) family [HveA (herpesvi-
rus entry mediator A)] (21), and modified heparan sulfate
(25). Nectins localize at the adherens junctions and me-
diate intercellular adhesion by homo- or hetero-trans
interactions with themselves or other members of the
nectin family (12, 24, 27). The family includes several
members, each with splice variant isoforms with com-
mon ectodomain and different C-terminal portions. The
focus of our interest is nectin1 (CD111) which appears as
the most likely candidate to sustain HSV infection in
humans because of its ability to serve as a receptor for
wt HSV, its expression in human tissues targeted by HSV,
and its ability to mediate virion-to-cell as well as cell-to-
cell spread (8, 9, 13). Other members of the family are
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6nectin2 (CD112), poliovirus receptor (PVR/CD155), nec-
tin3, and nectin4 (16, 23, 24). Nectins differ in the spec-
trum of viruses for which they serve as receptors. Thus,
nectin1 serves as receptor for all HSV-1 and -2 strains
tested, pseudorabiesvirus (PrV), and bovine herpesvirus
(BHV-1). Nectin2 serves as a receptor for HSV mutants
carrying mutations in gD at residue 25 or 27 (such as
HSV(U10), HSV(U21), rid-1 and -2), but not for wt HSV (16,
28). These mutations do not hamper the ability to use
nectin1; hence, the mutants can alternatively use nectin1
or nectin2. The mutants—initially named gD-unrestricted
mutants, or mutants resistant to gD-mediated interfer-
ence—were selected for their ability to overcome the
restriction to infection imposed by constitutive expres-
sion of gD, which sequesters gD receptors (e.g., nectin1)
and renders cells that do not express alternative recep-
tors resistant to infection (2, 4). PVR serves as receptor
for the animal PrV -herpesviruses and BHV-1, but not for
HSV. Nectin3 and -4, newly identified members of the
family, are nonfunctional as herpesvirus receptors
(23, 24).
The nectin domain functional in gD binding and virus
entry resides in the V-type N-terminal domain (7, 14, 16,
17). Typically, V-like domains are composed of two
-sheets, each made of parallel and antiparallel
-strands (named A–G) and two additional -strands,
CC. Much of the current effort in trying to elucidate the
molecular interaction that leads to HSV entry into cells
focuses on fine mapping of residues critical to the inter-of contiguous synergistic regions, 64–76 and 77–94, ea
efficiency. © 2002 Elsevier Science (USA)
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action with HSV gD. Previously, we constructed a panelch inde
of chimeric receptors, where progressively smaller por-
tions of human nectin1 were transferred to the corre-
sponding regions of PVR (6). The site on human nectin1
where the HSV entry site and gD-binding activity reside
was located to the 64- to 94-amino-acid region (predicted
to encode the CCC -strands and intervening loops),
confirming competition binding studies between gD and
a panel of antibodies to human nectin1 (14). In turn, the
64–94 region appeared to be composed of subregions. A
minimal entry site lies between residues 77 and 94
(C–C loop and C strand). The role of the 64–76 up-
stream region has received little attention. In its absence
the 77–94 nectin1 region mediates virus entry at low
efficiency, whereas, in its presence, the 77–94 portion
yields an efficiency of infection undistinguishable from
that of the entire V domain (6). In nectin2 the 75–81
region exhibited HSV entry activity, and 3 intervening
amino acids (corresponding to residues 75–77 in nec-
tin1) were sufficient (17).
The crystal structure of the HveA-gD complex has
been resolved, thus allowing the identification of critical
residues in the interaction (5). By contrast, the crystal
structure of nectin1 or of nectin1 bound to gD remains to
be resolved. This leaves mutagenesis as an approach to
defining critical residues to the interaction. The purpose
of the present studies was to investigate the role of the
64–76 nectin1 region and specifically to determine
whether it contains residues that are sufficient to medi-
ate virus entry or merely enhance the HSV entry activity
of the downstream minimal entry site. In order to exam-
ine the relative contribution of specific residues, we
transferred multiple or single amino acids in the corre-
sponding region (predicted C–C) of nectin2. This was
chosen as recipient receptor because it cannot serve as
a receptor for wt HSV (16, 28) and has an overall extent
of identity at the amino acid level of 34.6% in the V
domain (16). Cells expressing the chimeric receptors
were checked for cell surface expression and were
tested for their ability to be infected with wt HSV, the gD
mutants HSV-1(U10) and (U21), and the animal -herpes-
viruses PrV and BHV-1.
Results. Construction of mutant receptors carrying
multiple or single nectin1 residues in a nectin2 back-
bone. Immunoglobulin domains are rigid structures es-
sentially made of two -sheets and intervening loops
(schematic representation in Fig. 1D). Their mutagenesis
may present special problems, since substitutions of
residues located in -strands can cause loss of function,
not because the key residues that mediate the function
under study have been modified, but because the struc-
ture has been altered. To ensure that our results were
not dependent on inadvertent alteration of the V struc-
ture, we applied a gain-of-function approach based on
transfer of nectin1 residues into the corresponding po-
sition of nectin2 and acquisition of the ability to serve as
a wt HSV receptor.
Figure 1A shows the alignment of the V domains of
nectin1 and nectin2 performed with Align software. Fig-
ure 1B shows the region of interest and Fig. 1C shows
the mutant receptors that were generated. All constructs
were derived by site-directed mutagenesis of nectin2 (as
detailed under Materials and Methods) (11, 16), checked
by sequence, and designated by figures that denote the
nectin1 residues transferred to nectin2. The first con-
struct to be generated was the 72–75, followed by further
upstream mutagenesis to yield the 69–75 mutant. The
contribution of the upstream region was analyzed sepa-
rately in the 69–71 mutant, and that of shorter amino acid
combinations in the downstream region in the 73–75
construct, generated by mutagenesis of the 72–75 con-
struct. Three mutants carried single substitutions, N72,
S74, and K75.
Cell Surface Expression of Mutant Receptors. J cells,
devoid of HSV receptors and resistant to HSV infec-
tion, were transfected with constructs encoding the
mutant receptors. To assess that all mutant recep-
tors were expressed at the cell surface at comparable
levels, two series of experiments were performed. In
the first, live or formaldehyde-fixed transfected cells,
either as stable transformants or following transient
expression, were analyzed by FACS or by indirect im-
munofluorescence with MAb R2.477, a nonneutralizing
antibody directed to the C domains of nectin2 (see 16).
All mutant receptors were transported to the cell surface
at comparable levels, as can be seen by FACS analysis
in Fig. 2A. The IFA results were consistent (data not
shown).
In a second series of experiments, stable transfor-
mants were infected with the HSV(U10) mutant that can
use nectin2 as a receptor (16). Infection was at high
multiplicity of infection to ensure that all cells were in-
fected and was quantified 16 h after infection as reactiv-
ity of MAb30 to gD, followed by biotinylated antimouse
secondary antibody and streptavidin -gal. Results in
Fig. 2B show that all cells were similarly infected with
HSV(U10) at 20, 60, and 200 PFU/cell, confirming that
there was no defect in cell surface expression and,
furthermore, that receptor molecules were appropriately
folded and functional. The results ensure that the ex-
change of residues did not alter the overall structure of
the nectin2 Ig-type V domain.
Effect of Transferring Nectin1 Residues to Nectin2 on
HSV and Animal -Herpesvirus Entry. Cells expressing
the mutant receptors were infected with HSV-1(R8102),
HSV-2, PrV, and BHV-1 at increasing multiplicities of
infection. Infection with HSV-2 and BHV-1 was quantified
by immunoreactivity to the indicated antibodies, whereas
infection with HSV-1(R8102) and PrV recombinants was
quantified by means of the LacZ reporter gene. wt HSV-1
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(e.g., HSV-1(R8102)) and BHV-1 cannot use nectin2 and
only use nectin1 as receptor. HSV-2 and PrV exhibit
some entry activity in nectin2 cells. HSV(U10) and
HSV(U21) can use nectin2 as receptor, although not as
efficiently as nectin1. Consequently, the level of infection
in cells expressing wt nectin2 varied from practically
nothing for HSV-1 and BHV-1 to low for HSV-2 and PrV
and higher for HSV(U21). Some general patterns of in-
fection in cells expressing the chimeric nectin1/nectin2
receptors emerge (Figs. 3A–3D). Transfer of the strings of
residues 69–75, 69–71, and 72–75 conferred entry activity
to HSV-1, HSV-2, and BHV-1 or greatly increased the entry
efficiency of PrV. The sequence KST (distal portion of C
-strand) (69–71) was generally as effective as NGSK
(C–C loop) (72–75). This was somehow unexpected as
loops are structurally more flexible than -strands and
are predicted to provide surfaces suitable for protein–
protein interactions. Transfer of single residues was gen-
erally ineffective, except for N72 and HSV-2.
HSV(U21), similarly to HSV(U10), can enter cells
through nectin2, but at reduced efficiency compared to
entry through nectin1. This is reflected in the amount of
input virus required for an effective infection (16). We
exploited these differences to test whether the mutant
receptors could mediate HSV(U21) entry with efficiency
similar to that attained with nectin1 and therefore mea-
sured infection following exposure to low multiplicities of
infection. Figure 3E shows that the substitution of three
or four contiguous amino acids was sufficient to confer a
level of infection comparable to that of nectin1 (see
mutants 69–75, 69–71, 72–75, and 73–75). Among the
single substitutions, N72 and K75 significantly increased
FIG. 1. (A) Alignment of the V domain of human nectin1 and -2. The predicted C, C, and C -strands are shaded in gray. (B) Detail of the region
of interest. The mutagenized amino acids are boxed (69–75 for nectin1 and 71–78 for nectin2). (C) Designation and amino acid sequence of the nectin2
mutants: figures indicate the nectin1 amino acids that were transferred to the nectin2 backbone. Nectin1 amino acids are in capitals and underlined,
and nectin2 amino acids are lowercase. (D) Schematic drawing of the nectin1 V domain and location of the CC ridge.
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the efficiency of infection, while S74 had only a slight
effect.
Discussion. (i) A portion of seven amino acids from
nectin1 (69–75) that includes the predicted distal part of
the C -strand and the CC loop (see Fig. 1D) is sufficient
to confer upon nectin2 the ability to serve as a receptor
for wt HSV-1. Within this region, three-amino-acid-long
stretches are sufficient to confer wt HSV-1 entry activity.
The portion is also sufficient to mediate HSV-2 and
BHV-1 entry and to increase the entry efficiency of PrV
and HSV(U21) to levels observed with nectin1. Thus this
region is responsible for a wide virus range of nectin1.
The analogous region from human nectin2 confers upon
murine nectin2 the ability to serve as an HSV receptor
(17). Inasmuch as only a few residues of nectin1 are
sufficient to confer wt HSV entry activity on nectin2, it
seems likely that the region forms part of the contact
surface with gD or that a proper structural conformation
is achieved with the cooperation of several residues.
Amino acids in the CC loop are crucial for poliovirus
FIG. 2. (A) FACS analysis of cell surface expression of the mutant nectin2 receptors. J cells were transfected with the indicated constructs and
selected with neomycin G418 (1.6 mg of active compound/ml) for 14 days. Stable transformants expressing wt nectin2, mutant nectin2, or nectin1
receptors were stained with MAb R2.477 or MAb CK35, directed to nectin2 C domains and to nectin1, respectively, followed by antimouse FITC (Dako).
The parental J cell line was used as a negative control. (B) Infectivity of HSV(U10) in G418 selected cell lines expressing stably the mutant receptors.
Cells were infected at the indicated multiplicities of infection, and infection was revealed as immunostaining using anti-gD MAb30, followed by
streptavidin -gal, and ONPG as substrate. The experiments were run in triplicate. The standard error ranged from 0.6 to 2.0% of mean values.
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binding to its receptor, as well as for HIV gp120 binding
to CD4 (22), arguing that in the immunoglobulin-type
receptors this region is more prone to interaction, most
likely being more exposed on the cell surface. The find-
ing that the three amino acids lying distal in the C
-strand are sufficient to confer -herpesvirus entry ac-
tivity implies that in nectin1 even this portion is suffi-
ciently exposed and available for interaction with gD.
(ii) None of the residues that were analyzed singly
was sufficient by itself to confer HSV-1 receptor activity,
except for the N72 residue and HSV-2. Taking into ac-
count that none of the mutant receptors had HSV-1 entry
activity as high as that of nectin1 (Fig. 3) and that part of
the HSV entry activity resides also in the downstream
77–94 region (6), the interaction surface between gD and
nectin1 appears to be complex and made of a mosaic of
residues, a situation probably analogous to that of a
complex epitope. Altogether the nectin1 site that medi-
ates HSV entry appears to be composed of contiguous
subregions, each one independently able to mediate
entry, albeit at reduced efficiency. Their activity is syner-
gistic, as in combination they increase entry activity to
levels observed with whole nectin1, probably by confer-
ring the best fitting structural conformation. A non mutu-
ally exclusive possibility is that some residues in the
nectin2 69–75 or 77–94 regions may actually impede the
gD binding, so that the best structural fitting between
chimeric receptors and gD is achieved when both nec-
tin2 subregions are substituted with the corresponding
residues from nectin1.
(iii) Binding of cells expressing the mutant receptors
to soluble gD (gD290–299t), as measured in a cell
ELISA test, was low, not significantly above the back-
ground of gD binding to J cells (not shown). This was not
FIG. 3. Infectivity of human and animal -herpesvirus in cells expressing the mutant receptors. Cells were infected with the indicated viruses and
the multiplicities of infection indicated in boxes. (A and D) HSV-1(R8102) and PrV-LacZ recombinants were monitored as -gal activity, using ONPG
as substrate and reading at 405 nm. For all other viruses, infection was revealed as immunostaining using biotinylated antimouse as secondary
antibody followed by streptavidin -gal. Primary antibodies were (B) anti -TIF MAb LP1 (ascites 1:500); (C) MAb 1240 to BHV-1 gB (undiluted
hybridoma culture supernatant); (E) anti-gD MAb30 (ascites 1:400); transiently expressing cells (A, D) or stable transformants (B, C, E). The
experiments were run in triplicate. The standard error ranged from 0.6 to 2.0% of mean values.
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surprising in light of two considerations. First, the effi-
ciency of HSV entry into mutant receptor-expressing
cells was lower than that into nectin1-expressing cells
(Fig. 3A); second, at least three examples have been
provided where -herpesvirus entry occurs via nectin
receptors, yet in vitro binding of gD to the receptors is
either very weak or undetectable. The examples include
murine nectin1 that displays low-affinity binding to HSV
gD (18–20), binding of BHV gD to human nectin1 (10), and
binding of rid1 gD to human nectin2 or to murine/human
nectin2 receptors (17). The present finding reinforces the
notion that entry mediated by nectin receptors can take
place even through a weak interaction with gD.
(iv) Different -herpesviruses display somewhat dif-
ferent abilities to use the chimeric receptors. This im-
plies that different forms of -herpesvirus gD differ
somewhat in their interaction surface with nectin1, even
though the 69–75 region mediates entry of all the strains
tested. This is consistent with the notion that gDs from
different -herpesviruses exhibit different affinities to
nectin1, from very low (e.g., undetermined for BHV-1) to
very high (e.g., 0.13  0.07  106 M for PrV) (10). Surpris-
ingly, the highest affinity to human nectin1 is not ob-
served with human gD but with PrV gD.
In conclusion, mutational analysis of PVR and CD4 has
served as the basis for elucidating the molecular inter-
action of these receptors with their viral ligands and
supports the results of structural analysis. The present
analysis provides a functional mutational analysis to
molecularly define residues and surfaces of interaction.
Materials and Methods. Cells and viruses. Cells were
grown in Dulbecco’s modified Eagle’s medium supple-
mented with 5% fetal calf serum. The J1.1–2 cell line (J
cells), a derivative of BHKtk cells highly resistant to HSV
infection, was described previously (9), and used as a
receptor-negative recipient cell for Lipofectamine-medi-
ated transfection with the mutant receptors. The recom-
binants HSV-1(R8102) (used in place of wt HSV) and the
PrV gH (used in place of wt PrV) carrying a lacZ re-
ported gene were described previously (1, 19). PrV gH
was grown in SW78 cells, a complementing cell line
expressing PrV gH, both kindly provided by Dr. T. Metten-
leiter. The infectivity of the two recombinant viruses
was measured as -galactosidase (-gal) activity by
reading of the optical density at 405 nm following addi-
tion of ONPG (o-nitrophenyl--D-galactopyranoside) (9,
21). HSV(U10) and HSV(U21), selected for their ability to
overcome gD-mediated restriction to infection, carry the
following amino acid substitutions in gD, L25P, and L25P
plus A185T, respectively (2), and can use alternatively
nectin1 or nectin2 receptors (9, 16).
Immunoassay. The infection of HSV mutants HSV(U10)
and HSV(U21), HSV-2(G), and BHV-1 was measured by
immunoreactivity as follows. Cells were fixed at 16 hpi
with methanol at 20°C for 10 min. Following the block-
ing of nonspecific binding with 20% NCS in PBS for 30
min at 37°C, cells were incubated with MAb30 to HSV-1
gD, MAb LP1 to HSV -TIF (both ascites fluid 1:400 in
20% NCS in PBS), or MAb 1240 to BHV-1 gB (undiluted
hybridoma supernatant) for 2 h at 37°C, followed by
biotinylated antimouse secondary antibody and strepta-
vidin -gal (Sigma) 1:500 in PBS for 1 h 30 min at 37°C.
ONPG (3 mg/ml in PBS) was used as substrate. The
absorbance was read at 405 nm in a Bio-Rad Microplate
Reader.
Construction of the Mutant Receptors. The following
primers were used for site-directed mutagenesis:
PRR2_72–75Bam (CAG CGC CCA GAT GCA AAT GGA
TCC AAG CAG AAT GTG GCC GCC T), PRR2_69–75Sal
(CTG GTG ACC TGG CAG AAG TCG ACC AAT GGC TCC
AAG CAG AAT GTG GCC GC), PRR2_69–71Sal_long
(CTG GTG ACC TGG CAG AAG TCG ACC CCT GCG AAC
CAC CAG AAT GTG GCC GC), N72P (CAG CGC CCA GAT
GCA CCT GGC TCC AAG CAG AAT GTG G), N72_Stu
(GAC CTG GCA GAG GCC TGA TGC AAA TGC GAA CCA
CC), S74_Nhe (GAT GCA CCT GCT AGC CAC CAG AAT
GTG G), and K75_Nae (GCC CAG ATG CGC CGG CGA
ACA AGC AGA ATG TGG C). All the mutagenic oligos
were designed in order to introduce (or remove) a silent
restriction site, in order to facilitate the screening of the
mutants. Mutagenesis was carried out on nectin2 cloned
in the pLXSN vector under the control of a CMV promoter
for expression in mammalian cells. In the synthesis step
T4 polymerase was used to ensure high fidelity during
the polymerization reaction.
Expression of Mutant Receptors. J cells, devoid of HSV
receptors, and resistant to HSV infection (9), were trans-
fected with constructs encoding the mutant receptors by
using Lipofectamine reagent (Life Technologies). Cell
surface expression was determined by both FACS and
indirect immunofluorescence. For FACS analysis, live or
formaldehyde-fixed transfected cells either as stable
transformants (selected with 1.6 mg/ml of active com-
pound/ml of neomycin G418, for 14 days) or following a
30-h transient expression were stained with 2.5 mg/ml of
purified IgGs of MAb R2.477 to nectin2 followed by FITC-
conjugated goat antimouse antibody (Jackson Immu-
noresearch Laboratories) at 1:100. The samples were
read in a Beckman Coulter FACScan flow cytometer. All
MAb dilutions were done in PBS containing 5% fetal
bovine serum. For infectivity determinations, stable
transformants were infected with the HSV(U10) that can
use nectin2 as a receptor. After 16 h, infection was
quantified as reactivity to MAb30 to gD, followed by
biotinylated antimouse secondary antibody and strepta-
vidin -gal, as described above.
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